Received May 5, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
Swollen arm; arm redness; arm pain; This non-serious case was reported by a consumer via call center representative and described the occurrence of swelling arm in a 54-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On 21-APR-2026, the patient received the 1st dose of Shingrix. On 21-APR-2026, less than a day after receiving Shingrix, the patient experienced swelling arm (Verbatim: Swollen arm), erythema of extremities (Verbatim: arm redness) and pain in arm (Verbatim: arm pain). The outcome of the swelling arm, erythema of extremities and pain in arm were not resolved. It was unknown if the reporter considered the swelling arm, erythema of extremities and pain in arm to be related to Shingrix. It was unknown if the company considered the swelling arm, erythema of extremities and pain in arm to be related to Shingrix. Additional Information: GSK Receipt Date: 23-APR-2026 The batch number was not provided upon follow- up with the reporter.